A retrospective Sweden study revealed that individuals who subsequently developed ACPA-positive RA exhibited elevated levels of lysophospholipids and tryptophan metabolites years before symptom onset than those without a diagnosis of RA [92]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.